ORAMED PHARMACEUTICALS INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 941 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 126-150 of 782 matching filings.

Per page
25
Current page
6
3

3 filing

Filing date
02 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-79895

SCHEDULE 13D

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
19 Mar 2024
Reporting date
14 Mar 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
18 Mar 2024
Reporting date
12 Mar 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
Next action
Verify source filing
424B5 File 333-257926

PROSPECTUS SUPPLEMENT

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-35813

ANNUAL REPORT

Filing date
06 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
20 Feb 2024
Reporting date
20 Feb 2024
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jan 2024
Reporting date
30 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
23 Jan 2024
Reporting date
22 Jan 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
19 Jan 2024
Reporting date
17 Jan 2024
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jan 2024
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
21 Dec 2023
Reporting date
21 Dec 2023
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
18 Dec 2023
Reporting date
18 Dec 2023
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
09 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
26 Sep 2023
Reporting date
21 Sep 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .